Chiasma Inc (CHMA.OQ)
CHMA.OQ on NASDAQ Stock Exchange Global Select Market
6.21USD
23 May 2019
6.21USD
23 May 2019
Change (% chg)
$0.05 (+0.81%)
$0.05 (+0.81%)
Prev Close
$6.16
$6.16
Open
$6.17
$6.17
Day's High
$6.32
$6.32
Day's Low
$6.11
$6.11
Volume
19,226
19,226
Avg. Vol
33,712
33,712
52-wk High
$7.15
$7.15
52-wk Low
$1.20
$1.20
About
Chiasma, Inc. is a biopharmaceutical company. The Company is engaged in developing and commercializing oral forms of therapies that are available only by injection. Using its Transient Permeability Enhancer (TPE) technology platform, the Company is developing oral therapies. The Company has completed a Phase III clinical trial... (more)
Overall
| Beta: | -- |
| Market Cap(Mil.): | $70.64 |
| Shares Outstanding(Mil.): | 24.36 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CHMA.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 29.30 | 32.55 |
| EPS (TTM): | -1.28 | -- | -- |
| ROI: | -34.47 | 14.23 | 13.82 |
| ROE: | -35.41 | 15.46 | 15.24 |
Estimates